JAK1 Inhibition with Upadacitinib in a Patient with Refractory Severe Chronic Spontaneous Urticaria and Concomitant Rheumatoid Arthritis: Complete Resolution of Urticaria and Remission of Rheumatoid Arthritis

Podobne zapisy

• The progress of rheumatology in the 21st century potential uses of upadacitinib in rheumatoid arthritis and other inflammatory rheumatic diseases
  od: E. L. Nasonov, i wsp.
  Wydane: (2020-11-01)
• Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
  od: Ieva Lingytė, i wsp.
  Wydane: (2024-09-01)
• Efficacy and safety of upadacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
  od: Yi-Heng Xu, i wsp.
  Wydane: (2026-05-01)
• Different Biomarkers of Response to Treatment with Selective Jak-1 Inhibitors in Rheumatoid Arthritis
  od: Maurizio Benucci, i wsp.
  Wydane: (2023-08-01)
• Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years
  od: Christina Charles-Schoeman, i wsp.
  Wydane: (2024-01-01)